Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294

Molecular and Cellular Biology

Volumn 21, Issue 18, 2001, Pages 6122-6131

  Shen, Tianjie ^a   Horwitz, Kathryn B ^a   Lange, Carol A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; EPIDERMAL GROWTH FACTOR; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MYC PROTEIN; PROGESTERONE RECEPTOR; PROTEASOME; SERINE; STEROID HORMONE;

AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; CANCER GROWTH; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; ENZYME PHOSPHORYLATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN TARGETING; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

DOWN-REGULATION; FEMALE; HUMANS; LIGANDS; MAP KINASE KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, PROGESTERONE; SERINE; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED;

EID: 0035726623     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.18.6122-6131.2001     Document Type: Article

References (51)

1. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I
2. Ligand and DNA-dependent phosphorylation of human progesterone receptor in vitro
3. Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells
4. Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors
5. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation
6. Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phospho-serine site-specific monoclonal antibody
7. Inhibition of transcription selectively reduces the level of ubiquitinated histone H2B in chromatin
8. Level of ubiquitinated histone H2B in chromatin is coupled to ongoing transcription
9. Immunologic analysis of human breast cancer progesterone receptors. 1. Immunoaffinity purification of transformed receptors and production of monoclonal antibodies
10. Cyclin is degraded by the ubiquitin pathway
11. Biphasic regulation of breast cancer cell growth by progesterone: Role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1)
12. Prolactin, epidermal growth factor or transforming growth factor-alpha activate a mammary cell-specific enhancer in mouse mammary tumor virus-long terminal repeat
13. Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors
14. An N-terminal inhibitory function, IF, suppresses transcription by the A-isoform but not the B-isoform of human progesterone receptors
15. Yeast RSP5 and its human homolog hRPF1 potentiate hormone-dependent activation of transcription by human progesterone and glucocorticoid receptors
16. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
17. Mutagenic analysis of the destruction signal of mitotic cyclins and structural characterization of ubiquitinated intermediates
18. Identification of a phosphorylation site in the hinge region of the human progesterone receptor and additional amino-terminal phosphorylation sites
19. Hypothesis: Progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals
20. Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways
21. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome
22. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf
23. MEKK1 activation of human estrogen receptor alpha and stimulation of the agonistic activity of 4-hydroxytamoxifen in endometrial and ovarian cancer cells
24. The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation
25. The glucocorticoid receptor: Rapid exchange with regulatory sites in living cells
26. A sequence in the 5′ flanking region confers progestin responsiveness on the human c-myc gene
27. Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes
28. Progesterone receptor regulation in T47D human breast cancer cells: Analysis by density labeling of progesterone receptor synthesis and degradation and their modulation by progestin
29. Proteasome-dependent degradation of the human estrogen receptor
30. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily
31. Cellular progesterone receptor phosphorylation in response to ligands activating protein kinases
32. Convergence of progesterone with growth factor and cytokine signaling in breast cancer. Progesterone receptors regulate signal transducers and activators of transcription expression and activity
33. Identification of the gal4 suppressor Sug1 as a subunit of the yeast 26S proteasome
34. Isolation and characterization of SUG2. A novel ATPase family component of the yeast 26S proteasome
35. Destruction of Myc by ubiquitin-mediated proteolysis: Cancer-associated and transforming mutations stabilize Myc
36. Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis
37. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: Only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP
38. Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP
39. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
40. Hyperexpression of mitogen-activated protein kinase in human breast cancer
41. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex
42. Enhanced translation and increased turnover of c-myc proteins occur during differentiation of murine erythroleukemia cells
43. A highly conserved ATPase protein as a mediator between acidic activation domains and the TATA-binding protein
44. Progesterone receptor phosphorylation - Complexities in defining a functional role
45. Hormone-induced progesterone receptor phosphorylation consists of sequential DNA-independent and DNA-dependent stages: Analysis with zinc finger mutants and the progesterone antagonist ZK98299
46. The XPB subunit of repair/transcription factor TFIIH directly interacts with SUG1, a subunit of the 26S proteasome and putative transcription factor
47. Steroid hormone receptors and their regulation by phosphorylation
48. p34Cdc28-mediated control of Cln3 cyclin degradation
49. Crosstalk between estrogen receptors and growth factor signaling
50. Phosphorylation of human progesterone receptor by cyclin-dependent kinase 2 on three sites that are authentic basal phosphorylation sites in vivo
51. Identification of a group of Ser-Pro motif hormone-inducible phosphorylation sites in the human progesterone receptor